Page last updated: 2024-09-05

colistimethate sodium and Experimental Lung Inflammation

colistimethate sodium has been researched along with Experimental Lung Inflammation in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aydoğdu, M; Bacakoğlu, F; Berk Takır, H; Çeltik, A; Ergan, B; Ergün, R; Gaygısız, Ü; Gürsel, G; Gürün Kaya, A; Güven, P; Kalamanoğlu Balcı, M; Korkmaz Ekren, P; Saltürk, C; Sayıner, A; Töreyin, ZN; Ulubay, G; Uluer, H; Yalçın, A1
Hsieh, TC; Hsu, CW; Hsueh, PR; Jean, SS; Lam, C; Lee, WS1
Martin, SI; Moffatt-Bruce, S; Nunley, DR; Pope-Harman, A; Ross, P; Sopirala, MM1
BAINES, RD; RIFKIND, D1
Hattori, M; Kaneko, Y; Kumai, R; Maseki, N; Sakurai, M; Sampi, K1

Trials

1 trial(s) available for colistimethate sodium and Experimental Lung Inflammation

ArticleYear
Combination of pipemidic acid, colistin sodium methanesulfonate and nystatin may be less effective than nystatin alone for prevention of infection during chemotherapy-induced granulocytopenia in acute leukemia.
    Medical oncology and tumor pharmacotherapy, 1989, Volume: 6, Issue:4

    Topics: Acute Disease; Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Colistin; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Leukemia; Middle Aged; Nicotinic Acids; Nystatin; Pipemidic Acid; Pneumonia; Random Allocation

1989

Other Studies

4 other study(ies) available for colistimethate sodium and Experimental Lung Inflammation

ArticleYear
Evaluation of nephrotoxicity and prognosis in patients treated with colistin due to hospital-acquired pneumonia.
    Tuberkuloz ve toraks, 2017, Volume: 65, Issue:4

    Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Cohort Studies; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Pneumonia; Prognosis; Renal Insufficiency

2017
Treatment outcomes of patients with non-bacteremic pneumonia caused by extensively drug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolates: Is there any benefit of adding tigecycline to aerosolized colistimethate sodium?
    Medicine, 2018, Volume: 97, Issue:39

    Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Minocycline; Pneumonia; Retrospective Studies; Survival Rate; Taiwan; Tigecycline; Treatment Outcome

2018
Multidrug-resistant Acinetobacter baumannii pneumonia in lung transplant recipients.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2008, Volume: 27, Issue:7

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Infective Agents; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Lung Transplantation; Male; Minocycline; Pneumonia; Risk Factors; Tigecycline; Treatment Outcome

2008
INTRAVENOUS ADMINISTRATION OF SODIUM COLISTIMETHATE.
    JAMA, 1964, Oct-26, Volume: 190

    Topics: Administration, Intravenous; Blood Chemical Analysis; Colistin; Creatine; Creatinine; Humans; Injections, Intramuscular; Injections, Intravenous; Kidney Function Tests; Nitrogen; Pharmacology; Pneumonia; Probenecid; Pseudomonas Infections; Pyelonephritis; Sodium; Urea

1964